Exhibit 10.1
SEPARATION AGREEMENT AND GENERAL RELEASE
I, Mark Bachleda, in consideration of the obligations of Galera Therapeutics, Inc., a Delaware corporation (the “Company”), under that certain Employment, Confidentiality, Noncompete and Invention Rights Agreement (the “Agreement”), do hereby release and forever discharge, as of the date hereof, the Company and its affiliates and all present and former directors, officers, agents, representatives, employees, successors and assigns of the Company and its affiliates and the Company’s direct and indirect owners (collectively, the “Released Parties”) to the extent provided in this Separation Agreement and General Release (“General Release”) below, effective as of the Effective Date (as defined in Section 14 below).
|US-DOCS\143991513.4||
|US-DOCS\143991513.4||
|US-DOCS\143991513.4||
|US-DOCS\143991513.4||
BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT:
DATE: 8/16/2023 /s/ Mark Bachleda
MARK BACHLEDA
Enclosure: Information Disclosure
|US-DOCS\143991513.4||
Exhibit 1
Information Disclosure
|US-DOCS\143991513.4||